IL-4 down-regulates the responsiveness of human intraepithelial lymphocytes

Clinical and Experimental Immunology

Volumn 105, Issue 3, 1996, Pages 556-560

  Ebert, E C ^a   Roberts, A I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

IL 4; Intestinal lymphocytes; Intraepithelial lymphocytes; Lymphokine activated killer cells

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; CELL CYCLE; DOWN REGULATION; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INTESTINE MUCOSA; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029798706     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-782.x     Document Type: Article

References (31)

1. Mitchell LC, Davis LS, Lipsky PE. Promotion of human T lymphocyte proliferation by IL-4. J Immunol 1989; 142:1548-57.
2. Hu-Li J, Shevach EM, Mizuguchi J, Ohara J, Mosmann T, Paul WE. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J Exp Med 1987; 165:157-72.
3. Brown M, Hu-Li J, Paul WE. IL-4 B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. J Immunol 1988; 131:504-11.
4. Lehrnbecher T, Merz H, Sebald W, Poot M. Interleukin 4 drives phytohemagglutinin-activated T cells through several cell cycles: no synergism between interleukin 2 and interleukin 4. Cytokine 1991; 3:593-7.
5. Fernandez-Botran R, Kramer PH, Diamantstein T, O'Hara JW, Vitetta ES. B-cell stimulatory factor (BSF-1) promotes growth of helper T cell lines. J Exp Med 1986; 164:580-93.
6. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 1990; 144:2211-5.
7. + human T cells. J Immunol 1991; 146:4209-14.
8. Gallagher G, Wilcox F, Al-Azzawi F. Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells. Clin Exp Immunol 1988; 74:166-70.
9. Brooks B, Rees RC. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer activity. Clin Exp Immunol 1988; 74:162-5.
10. Kawakami Y, Custer MC, Rosenberg SA, Lotze MT. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J Immunol 1989; 142:3452-61.
11. James SP, Kwan WC, Sneller MC. T cells in inductive and effector compartments of the intestinal mucosul immune system of non-human primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function. J Immunol 1990; 144:1251-6.
12. Ebert EC. Proliferate responses of human intraepithelial lymphocytes to various T-cell stimuli. Gastroenterol 1989; 97: 1372-81.
13. Ebert EC, Roberts AI, Devereux D, Nagase H. Selective immunosuppressive action of a factor produced by colon cancer cells. Cancer Res 1990; 50:6158-61.
14. 1 antagonists reduce their proliferation and cytotoxicity. Cellular Immunol 1994; 156:212-9.
15. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23:3043-9.
16. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148:3578-82.
17. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterol 1995; 108:21-33.
18. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N. Impaired mucosal immune response in interleukin-4-targeted mice. J Exp Med 1995; 181:41-53.
19. Defrance T, Vanbervliet B, Aubry JP et al. B cell growth-promoting activity of recombinant human interleukin-4. J Immunol 1987; 139:1135-41.
20. Pandrau D, Saeland S, Duvert V, Durand I, Manel AM, Zabot MT, Phillippe N, Banchereau J. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J Clin Invest 1992; 90:1697-706.
21. Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 1990; 145:1740-4.
22. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89:4076-80.
23. Thornhill MH, Haskard DO. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J Immunol 1990; 145:865-72.
24. + T cells triggered via crosslinking of T3 cell surface structures. Eur J Immunol 1988; 18:707-12.
25. + human T cell subset. Int Immunol 1990; 2:685-9.
26. Deschanet J, Briolay J, Rissoan M-C, Chomarat P, Galizzi J-P, Banchereau J, Miossec P. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 1993; 151:4908-17.
27. Bosco MC, Pulkki K, Rowe TK, Zea AH, Musso T, Longo DL, Varesio L, Espinoza-Delgado I. IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor βg chain expression. J Immunol 1995; 155:1411-9.
28. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K. Sharing of the interleukin-2 receptor γ-chain between receptors for IL-2 and IL-4. Science 1993; 262:1874-7.
29. Holter W, Majdic O, Kalthoff FS, Knapp W. Regulation of interleukin-4 production in human mononuclear cells. Eur J Immunol 1992; 22:2765-7.
30. Flamand V, Abramowicz D, Goldman M, Biernaux C, Huez G, Urbain J, Moser M, Leo O. Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. J Immunol 1990; 144:2875-82.
31. + T cells can be primed in vitro to produce IL-4. J Immunol 1992; 148:1652-6.